0001493152-24-021962.txt : 20240530 0001493152-24-021962.hdr.sgml : 20240530 20240530160018 ACCESSION NUMBER: 0001493152-24-021962 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240523 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240530 DATE AS OF CHANGE: 20240530 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Qualigen Therapeutics, Inc. CENTRAL INDEX KEY: 0001460702 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 263474527 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37428 FILM NUMBER: 241005048 BUSINESS ADDRESS: STREET 1: 2042 CORTE DEL NOGAL STREET 2: CARLSBAD CITY: CALIFORNIA STATE: CA ZIP: 92011 BUSINESS PHONE: (760) 918-9165 MAIL ADDRESS: STREET 1: 2042 CORTE DEL NOGAL STREET 2: CARLSBAD CITY: CALIFORNIA STATE: CA ZIP: 92011 FORMER COMPANY: FORMER CONFORMED NAME: RITTER PHARMACEUTICALS INC DATE OF NAME CHANGE: 20090402 8-K 1 form8-k.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 23, 2024

Qualigen Therapeutics, Inc.

(Exact name of registrant as specified in its charter)

Delaware

001-37428

26-3474527

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(I.R.S. Employer

Identification No.)

5857 Owens Avenue, Suite 300, Carlsbad, California 92008

(Address of principal executive offices) (Zip Code)

(760) 452-8111

(Registrant’s telephone number, including area code)

n/a

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol		Name of each exchange on which registered
Common Stock, par value $.001 per share		QLGN		The Nasdaq Capital Market of The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act (§230.405 of this chapter) or Rule 12b-2 of the Exchange Act (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On May 23, 2024, Qualigen Therapeutics, Inc. (the “Company”) received written notice (the “Delist Notice”) from The Nasdaq Stock Market (“Nasdaq”) indicating the Company’s continued non-compliance with the minimum bid price requirement, pursuant to Listing Rule 5550(b)(2).

As previously reported, on November 20, 2023, the Company received a letter (the “Bid Price Deficiency Notice”) from Nasdaq notifying the Company that, because the closing bid price for its common stock has been below $1.00 per share for 30 consecutive business days, it no longer complies with the minimum bid price requirement for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share (the “Minimum Bid Price Requirement”), and Listing Rule 5810(c)(3)(A) provides that a failure to meet the Minimum Bid Price Requirement exists if the deficiency continues for a period of 30 consecutive business days.

Additionally, the Delist Notice states that since the Company has not yet filed its Form 10-Q for the period ended March 31, 2024, it no longer complies with Listing Rule 5250(c)(1), and that this matter serves as a separate and additional basis for delisting the Company’s securities from The Nasdaq Stock Market.

Further, as previously reported, on November 21, 2023, the Company also received a letter from Nasdaq notifying the Company that it did not comply with the $2,500,000 minimum stockholders’ equity requirement, as set forth in Listing Rule 5550(a)(2) (the “Equity Rule”). On January 12, 2024, Nasdaq granted the Company an extension of time until May 21, 2024, to regain compliance with the Equity Rule. The Company has not done so to date. As such, the Delist Notice states that this matter also serves as a separate and additional basis for delisting the Company’s securities from The Nasdaq Stock Market.

On May 30, 2024 the Company requested a hearing before a Nasdaq Hearings Panel, which will automatically stay the suspension of trading in the Company’s securities for a period of 15 days from the date of the request. The Company also intends to seek an extended stay pending the hearing, although no assurance can be provided that such an extension would be granted.

The Company is working to evidence compliance with all applicable requirements for continued listing on the Nasdaq Capital Market and intends to submit a plan to that effect to the Panel as part of the hearing process; however, there can be no assurance the Panel will grant any request for continued listing or that the Company will be able to regain compliance with the applicable listing criteria within the period of time that may be granted by the Panel.

The Notices have no immediate effect on the listing or trading of the Company’s common stock and the common stock will continue to trade on the Nasdaq Capital Market under the symbol “QLGN.”

Item 8.01 Other Events.

On May 30, 2024, the Company issued a press release announcing its receipt of the Delist Notice. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Forward-Looking Statements

Certain information contained in this Current Report on Form 8-K includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company may in some cases use terms such as “predicts,” “believes,” “potential,” “continue,” “anticipates,” “estimates,” “expects,” “plans,” “intends,” “may,” “could,” “might,” “likely,” “will,” “should” or other words that convey uncertainty of the future events or outcomes to identify these forward-looking statements. The Company’s forward-looking statements are based on current beliefs and expectations of its management team that involve risks, potential changes in circumstances, assumptions, and uncertainties, including statements regarding the Company’s plans to regain compliance with the Nasdaq continued listing requirements, including the Minimum Bid Price Requirement and the Minimum Stockholders’ Equity Requirement or its alternatives, the Company’s ability to file its Form 10-Q for the period ended March 31, 2024 or otherwise in the future, and the Company’s financial condition, growth and strategies. Any or all of the forward-looking statements may turn out to be wrong or be affected by assumptions the Company makes that later turn out to be incorrect, or by known or unknown risks and uncertainties. These forward-looking statements are subject to risks and uncertainties including risks related to the Company’s ability to regain compliance with Nasdaq’s continued listing requirements, including the Minimum Bid Price Requirement and the Minimum Stockholders’ Equity Requirement or its alternatives, the Company’s ability to file its Form 10-Q for the period ended March 31, 2024 or otherwise in the future, or otherwise maintain compliance with any other listing requirement of The Nasdaq Capital Market, the potential de-listing of the Company’s shares from The Nasdaq Capital Market due to its failure to comply with the Minimum Bid Price Requirement or the Minimum Stockholders’ Equity Requirement or its alternatives, and the Company’s ability to file its Form 10-Q for the period ended March 31, 2024 or otherwise in the future, and the other risks set forth in the Company’s filings with the Securities and Exchange Commission, including in its Annual Reports on Form 10-K and its Quarterly Reports on Form 10-Q. For all these reasons, actual results and developments could be materially different from those expressed in or implied by the Company’s forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements, which are made only as of the date of this Current Report on Form 8-K. The Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances unless required by law.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Number		Description
99.1		Press release issued by Qualigen Therapeutics, Inc. on May 30, 2024.

104		Cover Page Interactive Data File, formatting Inline Extensible Business Reporting Language (iXBRL).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	QUALIGEN THERAPEUTICS, INC.

Date: May 30, 2024	By:	/s/ Michael S. Poirier
		Michael S. Poirier, Chief Executive Officer

EX-99.1 2 ex99-1.htm

Exhibit 99.1

Qualigen Therapeutics, Inc. Received Nasdaq Notice of a Delisting Determination

CARLSBAD, Calif., May 30, 2024 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,” Nasdaq: QLGN), announced today that on May 23, 2024, it received written notice (the “Delist Notice”) from The Nasdaq Stock Market (“Nasdaq”) indicating the Company’s continued non-compliance with the minimum bid price requirement, pursuant to Listing Rule 5550(b)(2).

As previously reported, on November 20, 2023, the Company received a letter (the “Bid Price Deficiency Notice”) from Nasdaq notifying the Company that, because the closing bid price for its common stock has been below $1.00 per share for 30 consecutive business days, it no longer complies with the minimum bid price requirement for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share (the “Minimum Bid Price Requirement”), and Listing Rule 5810(c)(3)(A) provides that a failure to meet the Minimum Bid Price Requirement exists if the deficiency continues for a period of 30 consecutive business days.

Additionally, the Delist Notice states that since the Company has not yet filed its Form 10-Q for the period ended March 31, 2024, it no longer complies with Listing Rule 5250(c)(1), and that this matter serves as a separate and additional basis for delisting the Company’s securities from The Nasdaq Stock Market.

Further, as previously reported, on November 21, 2023, the Company also received a letter from Nasdaq notifying the Company that it did not comply with the $2,500,000 minimum stockholders’ equity requirement, as set forth in Listing Rule 5550(a)(2) (the “Equity Rule”). On January 12, 2024, Nasdaq granted the Company an extension of time until May 21, 2024, to regain compliance with the Equity Rule. The Company has not done so to date. As such, the Delist Notice states that this matter also serves as a separate and additional basis for delisting the Company’s securities from The Nasdaq Stock Market.

On May 30, 2024 the Company requested a hearing before a Nasdaq Hearings Panel, which will automatically stay the suspension of trading in the Company’s securities for a period of 15 days from the date of the request. The Company also intends to seek an extended stay pending the hearing, although no assurance can be provided that such an extension would be granted.

The Company is working to evidence compliance with all applicable requirements for continued listing on the Nasdaq Capital Market and intends to submit a plan to that effect to the Panel as part of the hearing process; however, there can be no assurance the Panel will grant any request for continued listing or that the Company will be able to regain compliance with the applicable listing criteria within the period of time that may be granted by the Panel.

The Notices have no immediate effect on the listing or trading of the Company’s common stock and the common stock will continue to trade on the Nasdaq Capital Market under the symbol “QLGN.”

About Qualigen Therapeutics, Inc.

For more information about Qualigen Therapeutics, Inc., please visit www.qlgntx.com.

Forward-Looking Statements

This news release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company may in some cases use terms such as “predicts,” “believes,” “potential,” “continue,” “anticipates,” “estimates,” “expects,” “plans,” “intends,” “may,” “could,” “might,” “likely,” “will,” “should” or other words that convey uncertainty of the future events or outcomes to identify these forward-looking statements. The Company’s forward-looking statements are based on current beliefs and expectations of its management team that involve risks, potential changes in circumstances, assumptions, and uncertainties, including statements regarding the Company’s plans to regain compliance with the Nasdaq continued listing requirements, including the Minimum Bid Price Requirement and the Minimum Stockholders’ Equity Requirement or its alternatives, the Company’s ability to file its Form 10-Q for the period ended March 31, 2024 or otherwise in the future, and the Company’s financial condition, growth and strategies. Any or all of the forward-looking statements may turn out to be wrong or be affected by assumptions the Company makes that later turn out to be incorrect, or by known or unknown risks and uncertainties. These forward-looking statements are subject to risks and uncertainties including risks related to the Company’s ability to regain compliance with Nasdaq’s continued listing requirements, including the Minimum Bid Price Requirement and the Minimum Stockholders’ Equity Requirement or its alternatives, the Company’s ability to file its Form 10-Q for the period ended March 31, 2024 or otherwise in the future, or otherwise maintain compliance with any other listing requirement of The Nasdaq Capital Market, the potential de-listing of the Company’s shares from The Nasdaq Capital Market due to its failure to comply with the Minimum Bid Price Requirement or the Minimum Stockholders’ Equity Requirement or its alternatives, and the Company’s ability to file its Form 10-Q for the period ended March 31, 2024 or otherwise in the future, and the other risks set forth in the Company’s filings with the Securities and Exchange Commission, including in its Annual Reports on Form 10-K and its Quarterly Reports on Form 10-Q. For all these reasons, actual results and developments could be materially different from those expressed in or implied by the Company’s forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements, which are made only as of the date of this news release. The Company disclaims any intent or obligation to update these forward-looking statements beyond the date of this news release, except as required by law. This caution is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

Contact:

Investor Relations

ir@qlgntx.com.

Source: Qualigen Therapeutics, Inc.

GRAPHIC 3 ex99-1_001.jpg GRAPHIC begin 644 ex99-1_001.jpg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end EX-101.SCH 4 qlgn-20240523.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 5 qlgn-20240523_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 qlgn-20240523_pre.xml XBRL PRESENTATION FILE XML 8 R1.htm IDEA: XBRL DOCUMENT

Cover	May 23, 2024
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	May 23, 2024
Entity File Number	001-37428
Entity Registrant Name	Qualigen Therapeutics, Inc.
Entity Central Index Key	0001460702
Entity Tax Identification Number	26-3474527
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	5857 Owens Avenue
Entity Address, Address Line Two	Suite 300
Entity Address, City or Town	Carlsbad
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	92008
City Area Code	(760)
Local Phone Number	452-8111
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Common Stock, par value $.001 per share
Trading Symbol	QLGN
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	false

EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://qlgntx.com/role/Cover Cover Cover 1 false false All Reports Book All Reports form8-k.htm qlgn-20240523.xsd qlgn-20240523_lab.xml qlgn-20240523_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form8-k.htm": { "nsprefix": "QLGN", "nsuri": "http://qlgntx.com/20240523", "dts": { "inline": { "local": [ "form8-k.htm" ] }, "schema": { "local": [ "qlgn-20240523.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "qlgn-20240523_lab.xml" ] }, "presentationLink": { "local": [ "qlgn-20240523_pre.xml" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://qlgntx.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-05-23", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-05-23", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://qlgntx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 16 0001493152-24-021962-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-24-021962-xbrl.zip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end XML 18 form8-k_htm.xml IDEA: XBRL DOCUMENT 0001460702 2024-05-23 2024-05-23 iso4217:USD shares iso4217:USD shares false 0001460702 8-K 2024-05-23 Qualigen Therapeutics, Inc. DE 001-37428 26-3474527 5857 Owens Avenue Suite 300 Carlsbad CA 92008 (760) 452-8111 false false false false Common Stock, par value $.001 per share QLGN NASDAQ false